Sex and Framingham Risk Score-adjusted RRs for CVD associated with levels of fasting, 2-h postchallenge, and average glycemia
. | Model 1 . | Model 2 . | Model 3 . | Model 4 . | Model 5 . | Model 6 . |
---|---|---|---|---|---|---|
FPG (per 0.7 mmol/l [13 mg/dl] increase) | ||||||
RR | 1.088 | 0.868 | 1.024 | |||
95% CI | 1.02–1.16 | 0.76–0.998 | 0.92–1.14 | |||
P | 0.008 | 0.046 | 0.7 | |||
2hPG (per 2.1 mmol/l [38 mg/dl] increase) | ||||||
RR | 1.182 | 1.42 | 1.232 | |||
95% CI | 1.10–1.27 | 1.17–1.72 | 1.07–1.43 | |||
P | 0.0001 | 0.0004 | 0.005 | |||
HbA1c (per 0.71% hemoglobin increase) | ||||||
RR | 1.151 | 1.115 | 0.929 | |||
95% CI | 1.02–1.30 | 0.92–1.35 | 0.77–1.13 | |||
P | 0.03 | 0.3 | 0.5 | |||
c-statistic | 0.752 | 0.749 | 0.740 | 0.741 | 0.745 | 0.741 |
. | Model 1 . | Model 2 . | Model 3 . | Model 4 . | Model 5 . | Model 6 . |
---|---|---|---|---|---|---|
FPG (per 0.7 mmol/l [13 mg/dl] increase) | ||||||
RR | 1.088 | 0.868 | 1.024 | |||
95% CI | 1.02–1.16 | 0.76–0.998 | 0.92–1.14 | |||
P | 0.008 | 0.046 | 0.7 | |||
2hPG (per 2.1 mmol/l [38 mg/dl] increase) | ||||||
RR | 1.182 | 1.42 | 1.232 | |||
95% CI | 1.10–1.27 | 1.17–1.72 | 1.07–1.43 | |||
P | 0.0001 | 0.0004 | 0.005 | |||
HbA1c (per 0.71% hemoglobin increase) | ||||||
RR | 1.151 | 1.115 | 0.929 | |||
95% CI | 1.02–1.30 | 0.92–1.35 | 0.77–1.13 | |||
P | 0.03 | 0.3 | 0.5 | |||
c-statistic | 0.752 | 0.749 | 0.740 | 0.741 | 0.745 | 0.741 |